HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dirk Geerts Selected Research

1- (4- (6- (2- (isopropylsulfonyl)phenylamino)- 9H- purin- 2- ylamino)- 3- ethoxyphenyl)piperidin- 4- ol

9/2013Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dirk Geerts Research Topics

Disease

34Neoplasms (Cancer)
01/2022 - 11/2007
19Neuroblastoma
01/2019 - 11/2007
7Breast Neoplasms (Breast Cancer)
01/2021 - 10/2014
5Carcinogenesis
01/2022 - 01/2014
5Inflammation (Inflammations)
01/2019 - 06/2012
5Neoplasm Metastasis (Metastasis)
01/2018 - 10/2014
4Glioblastoma (Glioblastoma Multiforme)
11/2016 - 09/2010
2Neuroinflammatory Diseases
01/2019 - 06/2012
2Astrocytoma (Pilocytic Astrocytoma)
07/2014 - 07/2014
2Glioma (Gliomas)
07/2014 - 07/2010
2Leukemia
08/2013 - 01/2013
2Multiple Sclerosis
02/2013 - 06/2012
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Endometrial Neoplasms (Endometrial Cancer)
01/2022
1Adenocarcinoma
12/2021
1Atrioventricular Block
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Bradycardia
01/2020
1Virus Diseases (Viral Diseases)
01/2019
1Rheumatoid Arthritis
01/2019
1Ulcerative Colitis
01/2019
1Ischemia
09/2018
1Necrosis
01/2018
1Osteosarcoma (Osteogenic Sarcoma)
01/2018
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2017
1Starvation
11/2016
1Obesity
01/2016
1Insulin Resistance
01/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2016
1Triple Negative Breast Neoplasms
10/2014

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
12/2021 - 11/2007
14Messenger RNA (mRNA)IBA
12/2021 - 11/2007
8PolyaminesIBA
01/2022 - 05/2010
5Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2008
4SpermidineIBA
01/2022 - 12/2014
4Pharmaceutical PreparationsIBA
01/2019 - 08/2009
4Eflornithine (Ornidyl)FDA Link
11/2018 - 04/2013
4Phosphotransferases (Kinase)IBA
01/2018 - 01/2010
4Small Interfering RNA (siRNA)IBA
01/2017 - 09/2014
3AntigensIBA
01/2022 - 01/2003
3OsteoprotegerinIBA
01/2020 - 10/2014
3Protein Isoforms (Isoforms)IBA
01/2019 - 07/2014
3Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
01/2018 - 05/2010
2hypusineIBA
01/2022 - 01/2018
2CytokinesIBA
01/2022 - 01/2017
2Peptides (Polypeptides)IBA
01/2022 - 06/2012
2Biological ProductsIBA
01/2020 - 12/2011
2TNF-Related Apoptosis-Inducing LigandIBA
01/2020 - 10/2014
2Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2019 - 06/2015
2EnzymesIBA
01/2019 - 01/2018
2Annexin A5IBA
01/2018 - 11/2007
2CationsIBA
01/2018 - 09/2014
2LigandsIBA
01/2017 - 03/2010
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 02/2013
2sepiapterin reductaseIBA
06/2015 - 01/2014
2PlectinIBA
07/2014 - 01/2003
1homeobox A1 proteinIBA
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
01/2022
1InterleukinsIBA
01/2022
1Calcibiotic Root Canal SealerIBA
01/2022
1Peptide Initiation Factors (Initiation Factor)IBA
01/2022
1cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1SodiumIBA
01/2020
1ChemokinesIBA
01/2020
1Poly I-CIBA
01/2019
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2019
1NADPH Oxidases (NAD(P)H oxidase)IBA
09/2018
1Drug CombinationsIBA
01/2018
1CaspasesIBA
01/2018
1Harmine (Telepathine)IBA
01/2018
1GlycosyltransferasesIBA
01/2018
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2018
1Tyrosine (L-Tyrosine)FDA Link
01/2018
1Calcium Channels (Calcium Channel)IBA
01/2018
1CC ChemokinesIBA
01/2017
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2017
1Monocyte Chemoattractant ProteinsIBA
01/2017
1Complementary DNA (cDNA)IBA
01/2017
1von Willebrand FactorIBA
01/2017
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2017
1Polysaccharides (Glycans)IBA
02/2016
1N-Acetylneuraminic Acid (Sialic Acid)IBA
02/2016
1sialic acid transport proteinsIBA
02/2016
1Myeloid Ecotropic Viral Integration Site 1 ProteinIBA
02/2016
1Amino AcidsFDA Link
02/2016
1LeptinIBA
01/2016
1Triglycerides (Triacylglycerol)IBA
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Fatty Acids (Saturated Fatty Acids)IBA
01/2016
1Caveolin 1IBA
01/2016
1SpermineIBA
06/2015
1N(1)-guanyl-1,7-diaminoheptaneIBA
12/2014
1deoxyhypusine synthaseIBA
12/2014

Therapy/Procedure

12Therapeutics
01/2022 - 08/2009
3Drug Therapy (Chemotherapy)
01/2018 - 08/2013
2Combined Modality Therapy
06/2015 - 12/2014
1Immunotherapy
01/2022
1Radiotherapy
11/2016